Obesity Clinical Trial
Official title:
Ileal Interposition to the Treatment of Weight Regain After Roux-en-Y Gastric Bypass: a Randomized Controlled Trial
The investigators will study the Ileal interposition to the treatment of weight regain after Roux-en-Y gastric bypass, assessing weight loss, body composition, quality of life, metabolic biomarkers, inflammatory biomarkers, and incretin hormones
Status | Recruiting |
Enrollment | 30 |
Est. completion date | May 1, 2026 |
Est. primary completion date | April 1, 2026 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 21 Years to 60 Years |
Eligibility | Inclusion Criteria: - Patients submitted to initial laparoscopic after initial Roux-en-Y gastric bypass for at least 3 years - Loss of excess weight between 60 to 80% - Rate of weight regain =60% - Body mass index = 40 kg/m2 or = 35 kg/m2, with at least 2 comorbidities associated with obesity - Present a previous evaluation by the multidisciplinary team with a favorable opinion of the revision surgery. Exclusion Criteria: - Active chemical dependency on alcohol and/or illicit drugs - Severe psychotic or depressive disorder or history of suicide attempts in the last 12 months - Eating behavior disorder (uncontrolled) - Secondary causes of obesity - Pregnancy - Severe organ failure - Active neoplastic - Infectious or inflammatory disease - Severe coagulopathy - High anesthetic-surgical risk - Intellectual inability - Lack of preoperative follow-up |
Country | Name | City | State |
---|---|---|---|
Brazil | State University of Rio de Janeiro | Rio de Janeiro |
Lead Sponsor | Collaborator |
---|---|
Rio de Janeiro State University |
Brazil,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Changes of weight loss of participants after Ileal interposition surgery as measured by weight in kilograms | Weight loss will be obtained as the difference between preoperative weight and minimum postoperative weight in kilograms | Change from baseline and after 6 months post-surgery | |
Primary | Changes of Health-related quality of life of participants after Ileal interposition surgery as reported by 36-Item Short-Form Health Survey questionnaire | Health-related quality of life will be assessed using the 36-Item Short-Form Health Survey questionnaire | Change from Baseline and after 6 months post-surgery | |
Secondary | Changes of weight loss of participants after Ileal interposition surgery as measured by weight in kilograms | Weight loss will be obtained as the difference between preoperative weight and minimum | Change from baseline and after 3, 6, and 12 months post-surgery | |
Secondary | Change of body composition of participants after Ileal interposition surgery as measured by lean and fat mass in kilograms | Body composition will be assessed through dual X-ray absorptiometry (DXA) | Change from baseline and after 6 and 12 months post-surgery | |
Secondary | Change of metabolic profile of participants after Ileal interposition surgery as assessed by serum levels of glucose and insulin | Blood sample collection will include serum levels of glucose and insulin | Change from baseline and after 6 and 12 months post-surgery | |
Secondary | Change of inflammatory biomarkers and incretin hormones of participants after Ileal interposition surgery as assessed by serum levels of tumor necrosis factor-alpha, interleukin-6, ghrelin, and glucagon-like peptide-1. | Blood sample collection will include serum levels of tumor necrosis factor-alpha, interleukin-6, ghrelin, and glucagon-like peptide-1. | Change from baseline and after 6 months post-surgery | |
Secondary | Changes in alcohol abuse of participants after Ileal interposition surgery as reported by Alcohol Use Disorders Identification Test | Alcohol abuse will be assessed using the Alcohol Use Disorders Identification Test | Change from baseline and after 6 and 12 months post-surgery | |
Secondary | Changes in depressive symptoms of participants after Ileal interposition surgery as reported by Beck Depression Inventory | Depressive symptoms will be assessed using the Beck Depression Inventory questionnaire | Change from baseline and after 6 and 12 months post-surgery | |
Secondary | Changes in the level of physical activity of participants after Ileal interposition surgery as reported by the International Physical Activity Questionnaire | Levels of physical activity will be assessed using the International Physical Activity Questionnaire | Change from baseline and after 6 and 12 months post-surgery | |
Secondary | Changes in the eating disorder symptoms of participants after Ileal interposition surgery as reported by the Eating Disorder Examination Questionnaire | Eating disorder symptoms will be assessed using the Eating Disorder Examination Questionnaire | Change from baseline and after 6 and 12 months post-surgery |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04243317 -
Feasibility of a Sleep Improvement Intervention for Weight Loss and Its Maintenance in Sleep Impaired Obese Adults
|
N/A | |
Recruiting |
NCT04101669 -
EndoBarrier System Pivotal Trial(Rev E v2)
|
N/A | |
Terminated |
NCT03772886 -
Reducing Cesarean Delivery Rate in Obese Patients Using the Peanut Ball
|
N/A | |
Completed |
NCT03640442 -
Modified Ramped Position for Intubation of Obese Females.
|
N/A | |
Completed |
NCT04506996 -
Monday-Focused Tailored Rapid Interactive Mobile Messaging for Weight Management 2
|
N/A | |
Recruiting |
NCT06019832 -
Analysis of Stem and Non-Stem Tibial Component
|
N/A | |
Active, not recruiting |
NCT05891834 -
Study of INV-202 in Patients With Obesity and Metabolic Syndrome
|
Phase 2 | |
Active, not recruiting |
NCT05275959 -
Beijing (Peking)---Myopia and Obesity Comorbidity Intervention (BMOCI)
|
N/A | |
Recruiting |
NCT04575194 -
Study of the Cardiometabolic Effects of Obesity Pharmacotherapy
|
Phase 4 | |
Completed |
NCT04513769 -
Nutritious Eating With Soul at Rare Variety Cafe
|
N/A | |
Withdrawn |
NCT03042897 -
Exercise and Diet Intervention in Promoting Weight Loss in Obese Patients With Stage I Endometrial Cancer
|
N/A | |
Completed |
NCT03644524 -
Heat Therapy and Cardiometabolic Health in Obese Women
|
N/A | |
Recruiting |
NCT05917873 -
Metabolic Effects of Four-week Lactate-ketone Ester Supplementation
|
N/A | |
Active, not recruiting |
NCT04353258 -
Research Intervention to Support Healthy Eating and Exercise
|
N/A | |
Completed |
NCT04507867 -
Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III
|
N/A | |
Recruiting |
NCT03227575 -
Effects of Brisk Walking and Regular Intensity Exercise Interventions on Glycemic Control
|
N/A | |
Completed |
NCT01870947 -
Assisted Exercise in Obese Endometrial Cancer Patients
|
N/A | |
Recruiting |
NCT05972564 -
The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function
|
Phase 1/Phase 2 | |
Recruiting |
NCT06007404 -
Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
|
||
Recruiting |
NCT05371496 -
Cardiac and Metabolic Effects of Semaglutide in Heart Failure With Preserved Ejection Fraction
|
Phase 2 |